Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Cytomegalovirus Retinitis during Maintenance Chemotherapy for Acute Leukemia

  • Ahn, Bin (Department of Pediatrics, Seoul National University Hospital) ;
  • Song, Seungha (Department of Pediatrics, Seoul National University Hospital) ;
  • Han, Mi Seon (Department of Pediatrics, Seoul National University Hospital) ;
  • Oh, Baek Lok (Department of Ophthalmology, Seoul National University Hospital) ;
  • Choi, Jae Hong (Department of Pediatrics, Jeju National University Hospital) ;
  • Choi, Eun Hwa (Department of Pediatrics, Seoul National University Hospital)
  • Received : 2020.03.17
  • Accepted : 2020.07.26
  • Published : 2020.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Cytomegalovirus (CMV) disease is rare in children who receive anticancer chemotherapy and have no history of stem cell transplantation (SCT). We report a case of CMV retinitis that developed during maintenance chemotherapy for acute leukemia. A 7-year-old boy developed decreased visual acuity and persistent pancytopenia during maintenance chemotherapy. Laboratory investigations initially showed significant CMV antigenemia (51 positive cells/200,000 leukocytes); however, antiviral therapy was not deemed necessary in this patient who had no history of SCT. CMV antigenemia worsened to 170 positive cells/200,000 leukocytes over 3 weeks. Ophthalmological examination revealed multiple bilateral retinal infiltrates and granular lesions. He was diagnosed with CMV retinitis and was treated with a 4-week course of intravenous ganciclovir and intravitreal injection of ganciclovir 6 times, followed by a 1-month course of orally administered valganciclovir. A CMV antigenemia assay showed negative results, and follow-up fundoscopy revealed lesser retinal infiltration after the sixth intravitreal ganciclovir injection. Future studies should focus on the development of standardized screening methods and preemptive therapeutic strategies for CMV disease in high-risk children.

거대세포바이러스병은 혈액종양 질환을 가진 환자군에서는 주로 조혈모세포이식을 받은 환자에게서 발현하는 것으로 보고되고 있으나, 드물게 조혈모세포이식을 받지 않고 항암 치료 중에 발현하는 경우가 있다. 저자들은 발열과 시력 저하를 주소로 입원한 7세 남자에게서 백혈병 유지 치료 중 발현한 거대세포바이러스 망막염을 진단하여 보고하는 바이다. 초기에 거대세포바이러스 항원혈증검사 수치가 51 positive cells/200,000 leukocytes로 높게 보고되었으나 조혈모세포이식을 받은 병력이 없어 항바이러스 치료를 시행하지 않았다가 3주 후 항원혈증검사 수치가 170 positive cells/200,000 leukocytes로 증가하여 시행한 안과 검진에서 양안의 망막 침범 소견과 과립형 병변이 확인되어 거대세포바이러스 망막염으로 진단되었다. 총 4주간의 정맥 내 ganciclovir 치료와 6회의 유리체강 내 ganciclovir 주입술을 시행한 후 경구 valganciclovir 치료를 1달간 더 시행하였다. 치료 시작 1달 후 거대세포바이러스 항원혈증검사가 음성이 되었고 안저검사에서 호전소견을 보였다. 본 증례와 같이 거대세포바이러스병에 이환되기 쉬운 고위험군 환자들에 대한 선별 검사와 적절한 치료방침에 대한 논의가 필요하겠다.

Keywords

References

  1. Drew WL. Diagnosis of cytomegalovirus infection. Rev Infect Dis 1988;10 Suppl 3:S468-76. https://doi.org/10.1093/clinids/10.Supplement_3.S468
  2. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 1988;10 Suppl 3:S460-7. https://doi.org/10.1093/clinids/10.Supplement_3.S460
  3. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009;22:76-98. https://doi.org/10.1128/CMR.00034-08
  4. Humar A, Michaels M; AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006;6:262-74. https://doi.org/10.1111/j.1600-6143.2005.01207.x
  5. Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004;4:611-20. https://doi.org/10.1111/j.1600-6143.2004.00382.x
  6. Razonable RR. Strategies for managing cytomegalovirus in transplant recipients. Expert Opin Pharmacother 2010;11:1983-97. https://doi.org/10.1517/14656566.2010.492395
  7. Han SB, Lee JH, Lee JW, Chung NG, Cho B, Kang JH, et al. Cytomegalovirus retinitis diagnosed after completion of chemotherapy for acute lymphoblastic leukemia in an adolescent. J Pediatr Hematol Oncol 2015;37:e128-30. https://doi.org/10.1097/MPH.0000000000000252
  8. Samia L, Hamam R, Dbaibo G, Saab R, El-Solh H, Abboud M, et al. Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma 2014;55:1918-21. https://doi.org/10.3109/10428194.2013.854887
  9. Wakai K, Sano H, Shimada A, Shiozawa Y, Park MJ, Sotomatsu M, et al. Cytomegalovirus retinitis during maintenance therapy for T-cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2013;35:162-3. https://doi.org/10.1097/MPH.0b013e318279e920
  10. Singh R, Singh R, Trehan A, Jain R, Bhalekar S. Cytomegalovirus retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone. J Pediatr Hematol Oncol 2013;35:e118-9. https://doi.org/10.1097/MPH.0b013e31827078ad
  11. Moritake H, Kamimura S, Kojima H, Shimonodan H, Harada M, Sugimoto T, et al. Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2013;60:329-31. https://doi.org/10.1002/pbc.24298
  12. Kobayashi R, Takanashi K, Suzuki D, Nasu T, Uetake K, Matsumoto Y. Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia. Pediatr Int 2012;54:288-90. https://doi.org/10.1111/j.1442-200X.2011.03429.x
  13. Baumal CR, Levin AV, Read SE. Cytomegalovirus retinitis in immunosuppressed children. Am J Ophthalmol 1999;127:550-8. https://doi.org/10.1016/S0002-9394(99)00031-8
  14. Demir SO, Celiker H, Karaaslan A, Kadayifci EK, Akkoc G, Atici S, et al. Cytomegalovirus retinitis in three pediatric cases with acute lymphoblastic leukemia: case series and review of the literature. Jpn J Infect Dis 2016;69:534-8. https://doi.org/10.7883/yoken.JJID.2015.223
  15. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America [Internet]. Washington, D.C.: United States Department of Health and Human Services; 2020 [cited 2020 Feb 10]. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.
  16. Jain R, Trehan A, Mishra B, Singh R, Saud B, Bansal D. Cytomegalovirus disease in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2016;33:239-47. https://doi.org/10.3109/08880018.2016.1173147
  17. Rahbarimanesh A, Ehsani M, Karahroudi M, Rashidi A, Aghajani M, Meysami A, et al. Cytomegalovirus disease in children with acute lymphoblastic leukemia in the nontransplant setting: case series and review of the literature. J Pediatr Hematol Oncol 2015;37:429-32. https://doi.org/10.1097/MPH.0000000000000298
  18. Zweiman B, Atkins PC, Bedard PM, Flaschen SL, Lisak RP. Corticosteroid effects on circulating lymphocyte subset levels in normal humans. J Clin Immunol 1984;4:151-5. https://doi.org/10.1007/BF00915049

Cited by

  1. Antineoplastics : Various toxicities: case report vol.1846, pp.1, 2020, https://doi.org/10.1007/s40278-021-92288-7